Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 3370

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT07737951
Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia
Tai Chi for Reducing Aromatase In… Cancer Non applicable RECRUITING En attente / non publié Thomas Jefferson University United States · Sidney Kimmel Cancer Center at Thomas… 2026-07-27 → 2029-06 Ouvrir
NCT07543536
MEGA-TACT-BC3 — Megestrol Acetate for Fatigue Management in T-DXd Treat…
Megestrol Acetate + Trastuzumab D… Cancer Phase 3 RECRUITING En attente / non publié Sun Yat-sen University China · Sun Yat-sen University Cancer Center, Guangzh… 2026-06-08 → 2031-04-01 Ouvrir
NCT05259839
A Study to Assess Adverse Events and Change in Disease Activity of Intr…
Etentamig Cancer Phase 1 ACTIVE_NOT_RECRUITING En attente / non publié AbbVie United States, Australia, Germany, Italy, Japan, Pola… 2022-10-20 → 2033-09 Ouvrir
NCT07758634
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Parti…
CTX340 Hypertension Phase 1/2 RECRUITING En attente / non publié CRISPR Therapeutics AG United States, Australia · Research Site 1, Port Oran… 2026-08-08 → 2029-07-01 Ouvrir
NCT02266329
Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial o…
prazosin hydrochloride Migraine Phase 1/2 COMPLETED En attente / non publié VA Office of Research and Develop… United States · VA Puget Sound Health Care System Sea… 2016-01-04 → 2023-09-30 Ouvrir
NCT06489561
Neural Computations of Goal-directed Decision-making
Neural Computations of Goal-direc… Épilepsie Non applicable ENROLLING_BY_INVITATION En attente / non publié Cedars-Sinai Medical Center United States · Cedars-Sinai Medical Center, Los Ange… 2023-08-01 → 2028-07-01 Ouvrir
NCT05419492
ENDEAVOR — A Clinical Study to Evaluate the Safety and Efficacy of ETX1…
ETX101 Épilepsie Phase 1/2 RECRUITING En attente / non publié Encoded Therapeutics United States, Australia, United Kingdom · Ann & Robe… 2024-05-14 → 2033-01 Ouvrir
NCT06063850
GenTLE — AMT-260 Gene Therapy Study in Adults With Unilateral Refractor…
AAV9-hSyn1-miGRIK2 Épilepsie Phase 1/2 RECRUITING En attente / non publié UniQure Biopharma B.V. United States · Allegheny Health Network, Pittsburgh,… 2024-06-12 → 2031-12 Ouvrir
NCT05737784
A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset…
PRAX-222 - Initial Dose Épilepsie Phase 1/2 ACTIVE_NOT_RECRUITING En attente / non publié Praxis Precision Medicines United States, Brazil · Hospital de Clínicas de Porto… 2023-04-13 → 2028-02 Ouvrir
NCT06092346
A Natural History Study Seeks to Understand the Clinical, Genomic, Phar…
A Natural History Study Seeks to … Épilepsie À vérifier RECRUITING En attente / non publié National Human Genome Research In… United States · National Institutes of Health Clinica… 2023-12-19 → 2099-01-01 Ouvrir
NCT06976268
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a …
BHV-8000 10mg Parkinson Phase 2/3 RECRUITING En attente / non publié Biohaven Therapeutics Ltd. United States · Site-003, Irvine, United States | Sit… 2025-05-28 → 2028-09 Ouvrir
NCT07751640
Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intra…
Autologous Bone Marrow Aspirate (… Parkinson Phase 1/2 ACTIVE_NOT_RECRUITING En attente / non publié Apeiron Research Center United States · Boulder Biologics Research Center, Bo… 2025-05-01 → 2026-09-04 Ouvrir
NCT06469944
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-…
Pembrolizumab Parkinson Phase 1/2 RECRUITING En attente / non publié Merck Sharp & Dohme LLC United States, Brazil, Chile, China, France, Germany,… 2024-09-20 → 2029-09-12 Ouvrir
NCT07411664
Objective Longitudinal Assessment of Postural Stability and Gait of Str…
Stroke posturo/3D group Parkinson Non applicable ENROLLING_BY_INVITATION En attente / non publié Somogy Megyei Kaposi Mór Teaching… Hungary · Somogy County Kaposi Mór Teaching Hospital,… 2026-03-01 → 2027-03-01 Ouvrir
NCT03969927
User-friendliness of a Portable Driving Simulator
Low-Fidelity PDS Parkinson Non applicable COMPLETED En attente / non publié University of Kansas Medical Cent… United States · Abiodun Akinwuntan, Kansas City, Unit… 2019-08-28 → 2025-06-01 Ouvrir
NCT06869278
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurol…
LCAR-AIO T cells SEP Phase 1 WITHDRAWN En attente / non publié Union Hospital, Tongji Medical Co… China · The Affiliated Hospital of Fujian Medical Uni… 2025-06-17 → 2025-06-17 Ouvrir
NCT07410806
HEALEY ALS Platform Trial - Regimen I NUZ-001
NUZ-001 Sclérose latérale amyotrophique Phase 2/3 ACTIVE_NOT_RECRUITING En attente / non publié Merit E. Cudkowicz, MD United States · Healey Center for ALS at Massachusett… 2026-02-25 → 2028-08-01 Ouvrir
NCT06719947
tDCS-ALS — HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Rand…
Active HD-tDCS Sclérose latérale amyotrophique Phase 2/3 RECRUITING En attente / non publié Universidade Federal do Rio Grand… Brazil, Chile · PneumoCardioVascular Lab - HUOL/UFRN,… 2025-11-28 → 2028-09-01 Ouvrir
NCT04297683
HEALEY ALS Platform Trial - Master Protocol
Zilucoplan Sclérose latérale amyotrophique Phase 2/3 ACTIVE_NOT_RECRUITING En attente / non publié UCB Biopharma SRL United States · Atrium Health, Charlotte, United Stat… 2020-06-14 → 2028-08 Ouvrir
NCT06351592
GOALS — First in Human (FIH) Study of ALN-SOD in Adult Participants Wit…
ALN-SOD Sclérose latérale amyotrophique Phase 1/2 RECRUITING En attente / non publié Regeneron Pharmaceuticals Australia, Belgium, Canada, Germany, Japan, Poland, S… 2024-08-28 → 2032-03-21 Ouvrir
NCT05470478
iBCI Optimization for Veterans With Paralysis
Mobile neural decoding platform (… Sclérose latérale amyotrophique Non applicable NOT_YET_RECRUITING En attente / non publié VA Office of Research and Develop… United States · Providence VA Medical Center, Provide… 2026-10-02 → 2027-06-30 Ouvrir
NCT06193889
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, …
Standard lymphodepletion regimen Myasthénie Phase 2/3 RECRUITING En attente / non publié Kyverna Therapeutics United States, Australia, Brazil, Germany, Saudi Arab… 2024-08-28 → 2028-09 Ouvrir
NCT06940323
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
Pregnancy Registry, Infants, Seru… Myasthénie À vérifier RECRUITING En attente / non publié University of California, San Fra… United States · University of California-San Francisc… 2017-03-21 → 2035-06 Ouvrir
NCT05693142
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne M…
RGX-202 Myopathies Phase 2/3 ACTIVE_NOT_RECRUITING En attente / non publié REGENXBIO Inc. United States, Canada · Ann & Robert H. Lurie Childre… 2023-01-04 → 2028-06 Ouvrir
NCT05554835
GENOMIT — Global Registry and Natural History Study for Mitochondrial D…
GENOMIT — Global Registry and Nat… Myopathies À vérifier RECRUITING En attente / non publié LMU Klinikum Austria, Germany, Italy · AOU City of Health and Scie… 2009-02-01 → 2040-12 Ouvrir